Suppr超能文献

功能性肠病中的益生菌

Probiotics in functional bowel disorders.

作者信息

Hod Keren, Ringel Yehuda

机构信息

Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Department of Gastroenterology, Rabin Medical Center, Petach Tikva, Israel; Department of Medicine, University of North Carolina School of Medicine at Chapel Hill, NC, USA.

出版信息

Best Pract Res Clin Gastroenterol. 2016 Feb;30(1):89-97. doi: 10.1016/j.bpg.2016.01.003. Epub 2016 Jan 14.

Abstract

Functional bowel disorders (FBDs) are the most common gastrointestinal (GI) disorders seen by gastroenterologists and primary care physicians. The disorders affect patients functioning and quality of life (QOL) and are associated with significant healthcare burden. The current theory regarding the development of FBDs suggests brain-gut axis dysfunctions associated abnormal GI motility and sensation. Recent data suggest that alterations in the intestinal microbiota may have a role in the pathogenesis of FBDs; or at least have the potential to affect intestinal functions that are thought to be relevant to the development of functional GI symptoms. This has led to growing interest of healthcare providers and patients in targeting the intestinal microbiota for the treatment of FBDs. In this article we discuss the potential role probiotic interventions in the treatment of FBDs. We review the evidence from pre-clinical and clinical studies and discuss the current recommendations for the use of probiotics for FBDs in clinical practice.

摘要

功能性肠病(FBDs)是胃肠病学家和初级保健医生所诊治的最常见的胃肠道(GI)疾病。这些疾病会影响患者的功能和生活质量(QOL),并带来巨大的医疗负担。目前关于功能性肠病发病机制的理论认为,脑-肠轴功能障碍与胃肠动力和感觉异常有关。最近的数据表明,肠道微生物群的改变可能在功能性肠病的发病机制中起作用;或者至少有可能影响被认为与功能性胃肠症状发展相关的肠道功能。这使得医疗服务提供者和患者越来越关注针对肠道微生物群来治疗功能性肠病。在本文中,我们讨论益生菌干预在功能性肠病治疗中的潜在作用。我们回顾了临床前和临床研究的证据,并讨论了目前在临床实践中使用益生菌治疗功能性肠病的建议。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验